期刊
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY
卷 8, 期 4, 页码 983-991出版社
SPRINGER
DOI: 10.1007/BF03246554
关键词
Imidazole; 1,8-Acridinedione; Cytotoxicity; Calcium channel antagonist activity
资金
- Tehran University of Medical Sciences (TUMS)
- University of Tehran (TU)
- Iran National Science Foundation (INSF)
- Medicinal and Natural Product Chemistry Research Center, Shiraz, Iran
A series of novel imidazolyl derivatives of fully and partially hydrogenated 1,8-acridinediones were synthesized and assessed for their cytotoxic activity on four different human cancer cell lines (HeLa, MCF-7, LS-180, and Raji cells). Although being inactive on LS-180 and Raji cell lines, the compounds showed weak to moderate anti-tumor activities on other cell lines and their IC50 ranged from 31.7 to more than 100 mu M. Among the synthesized compounds 12b, 13b, 12c and 13c, bearing an electron-attracting substituent on the imidazole ring, and 12f and 13f, with a benzyl substituent, showed higher activities. Furthermore, the calcium channel antagonist activity of the derivatives, an undesired effect when these compounds are used as anti-tumor agents, was much lower than that of Nifedipine, a reference antagonist. Imidazolyl derivatives of 1,8-acridinedione represent an interesting template, showing promising biological properties. Further investigation on this chemical scaffold could potentially lead to the discovery of cytotoxic agents with low calcium channel blocking activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据